Your account is not claimed yet. You can sign up with ORCID to claim your account.

Davide Cangelosi

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Venues

Cancers

Journal of proteome research

Scientific reports

Life (Basel, Switzerland)

Istituto Giannina Gaslini

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Giannina Gaslini Nov 1o 2011 - Oct 10o 2019

Italy

Research contract :: Dipartimento Ricerca Traslazionale, Medicina di Laboratorio, Diagnostica e Servizi, Laboratorio di Biologia Molecolare/Laboratory of Molecular BiologyDipartimento Ricerca Traslazionale, Medicina di Laboratorio, Diagnostica e Servizi, Laboratorio di Biologia Molecolare/Laboratory of Molecular Biology

Publications

Marzia Ognibene, Annalisa Pezzolo, Roberto Cavanna, Davide Cangelosi, Stefania Sorrentino, Stefano Parodi
A Simple, Test-Based Method to Control the Overestimation Bias in the Analysis of Potential Prognostic Tumour Markers. Cancers 15 (4) (2023)
Marzia Ognibene, Annalisa Pezzolo, Roberto Cavanna, Davide Cangelosi, Stefania Sorrentino, Stefano Parodi
A Simple, Test-Based Method to Control the Overestimation Bias in the Analysis of Potential Prognostic Tumour Markers. Cancers 15 (4) (2023)
Marzia Ognibene, Annalisa Pezzolo, Roberto Cavanna, Davide Cangelosi, Stefania Sorrentino, Stefano Parodi
A Simple, Test-Based Method to Control the Overestimation Bias in the Analysis of Potential Prognostic Tumour Markers. Cancers 15 (4) (2023)
Giuseppina Conteduca, Davide Cangelosi, Simona Coco, Michela Malacarne, Chiara Baldo, Alessia Arado, Rute Pinto, Barbara Testa, Domenico A Coviello
NSD1 Mutations in Sotos Syndrome Induce Differential Expression of Long Noncoding RNAs, miR646 and Genes Controlling the G2/M Checkpoint. Life (Basel, Switzerland) 12 (7) (2022)
Marzia Ognibene, Loredana Amoroso, Fraia Melchionda, Davide Cangelosi, Federico Zara, Stefano Parodi, Annalisa Pezzolo
High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene TSSC1. Cancers 13 (22) (2021)
Paolo Uva, Maria Carla Bosco, Alessandra Eva, Massimo Conte, Alberto Garaventa, Loredana Amoroso, Davide Cangelosi
Connectivity Map Analysis Indicates PI3K/Akt/mTOR Inhibitors as Potential Anti-Hypoxia Drugs in Neuroblastoma. Cancers 13 (11) (2021)
Davide Cangelosi, Martina Morini, Nicolò Zanardi, Angela Rita Sementa, Marco Muselli, Massimo Conte, Alberto Garaventa, Ulrich Pfeffer, Maria Carla Bosco, Luigi Varesio, Alessandra Eva
Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming. Cancers 12 (9) (2020)
Davide Cangelosi, Roberta Resaz, Andrea Petretto, Daniela Segalerba, Marzia Ognibene, Federica Raggi, Luca Mastracci, Federica Grillo, Maria Carla Bosco, Luigi Varesio, Antonio Sica, Irma Colombo, Alessandra Eva
A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization. Journal of proteome research 18 (7) (2019)
Francesca Piaggio, Veronica Tozzo, Cinzia Bernardi, Michela Croce, Roberto Puzone, Silvia Viaggi, Serena Patrone, Annalisa Barla, Domenico Coviello, Martine J Jager, Pieter A van der Velden, Michael Zeschnigk, Davide Cangelosi, Alessandra Eva, Ulrich Pfeffer, Adriana Amaro
Secondary Somatic Mutations in G-Protein-Related Pathways and Mutation Signatures in Uveal Melanoma. Cancers 11 (11) (2019)
Nicolò Zanardi, Martina Morini, Marco Antonio Tangaro, Federico Zambelli, Maria Carla Bosco, Luigi Varesio, Alessandra Eva, Davide Cangelosi
PIPE-T: a new Galaxy tool for the analysis of RT-qPCR expression data. Scientific reports 9 (1) (2019)

Davide Cangelosi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Davide Cangelosi